| Name | Title | Contact Details |
|---|
Envisia Therapeutics, formed by Liquidia Technologies in 2013, is a privately held biotechnology company focused on the development of novel ocular therapies. Envisia is leveraging the unique and powerful properties of the PRINT® platform to develop therapies for a variety of ocular conditions, the most advanced of which is ENV515, for the treatment of glaucoma. ENV515 is a novel extended-release formulation of a prostaglandin analogue formulation. It has the potential to significantly limit disease progression and vision loss through improved product performance and patient compliance. Envisia is located in Research Triangle Park, North Carolina.
Our passion for helping older adults is not something that has developed over night. With 26 years of commitment, our family owned organization has proven to excel in giving loving care to those in need of assistance. It is our mission to provide compassionate care to seniors in a real home environment. We feel that a smaller setting is most ideal for one to receive individual attention and continue establishing meaningful relationships between peers. Our goal is focused on improving the physical and emotional well-being of our residents to help maintain their independence. We are committed to upholding the highest standards of care as we strive to improve quality of life.
Roger Green and Associates is a New Hope, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BLOSSOM SOUTH is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ASE Direct, Inc. is a Service Disabled Veteran Owned Small Business that provides a comprehensive range of products and solutions for procurement applications. With an extensive national distribution network, ASE Direct delivers innovative systems and ...